Xu T - Search Results

1

MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.

Chen Z, Ma T, Huang C, Zhang L, Lv X, Xu T, Hu T, Li J. Chen Z, et al. Among authors: xu t. Cell Signal. 2013 Dec;25(12):2693-701. doi: 10.1016/j.cellsig.2013.08.032. Epub 2013 Sep 7. Cell Signal. 2013. PMID: 24018051

2

New advances of microRNAs in the pathogenesis of rheumatoid arthritis, with a focus on the crosstalk between DNA methylation and the microRNA machinery.

Miao CG, Yang YY, He X, Xu T, Huang C, Huang Y, Zhang L, Lv XW, Jin Y, Li J. Miao CG, et al. Among authors: xu t. Cell Signal. 2013 May;25(5):1118-25. doi: 10.1016/j.cellsig.2013.01.024. Epub 2013 Feb 4. Cell Signal. 2013. PMID: 23385088 Review.

3

MicroRNA-323-3p: a new biomarker and potential therapeutic target for rheumatoid arthritis.

Xu T, Huang C, Chen Z, Li J. Xu T, et al. Rheumatol Int. 2014 May;34(5):721-2. doi: 10.1007/s00296-013-2767-3. Epub 2013 Apr 25. Rheumatol Int. 2014. PMID: 23615628

4

5,7,3'-Triacetyl hesperetin suppresses adjuvant-induced arthritis in rats through modulating JAK2/STAT3 pathway.

Ren DY, Xu T, Li R, Huang C, Huang Y, Li RQ, Li HY, Li J. Ren DY, et al. Among authors: xu t. Am J Chin Med. 2013;41(3):601-14. doi: 10.1142/S0192415X13500420. Am J Chin Med. 2013. PMID: 23711144

5

Sphingosine kinase 2: a controversial role in arthritis.

Xu T, Li L, Huang C, Peng Y, Li J. Xu T, et al. Rheumatol Int. 2014 Jul;34(7):1015-6. doi: 10.1007/s00296-013-2831-z. Epub 2013 Jul 24. Rheumatol Int. 2014. PMID: 23881266

6

Controversial correlation between Fcγ receptor IIB and Toll-like receptor 2 in rheumatoid arthritis: comment on the article by Abdollahi-Roodsaz et al.

Xu T, Huang C, Li J, Li Y, Deng Z. Xu T, et al. Arthritis Rheum. 2013 Dec;65(12):3314. doi: 10.1002/art.38186. Arthritis Rheum. 2013. PMID: 24022363 Free article. No abstract available.

7

MicroRNA-148a: a potential therapeutic target for cancer.

Chen Z, Ma T, Huang C, Zhang L, Xu T, Hu T, Li J. Chen Z, et al. Among authors: xu t. Gene. 2014 Jan 1;533(1):456-7. doi: 10.1016/j.gene.2013.09.067. Epub 2013 Sep 29. Gene. 2014. PMID: 24084367

8

IL-2 is a gradually proved potential therapeutic target for hepatocellular carcinoma.

Xu T, Meng XM, Yao HW, Li J. Xu T, et al. Dig Liver Dis. 2014 Mar;46(3):289-90. doi: 10.1016/j.dld.2013.10.003. Epub 2013 Nov 13. Dig Liver Dis. 2014. PMID: 24239043 No abstract available.

9

Toll-like receptor (TLR)-3: a potent driving force behind rheumatoid arthritis.

Li X, Xu T, Wang Y, Huang C, Li J. Li X, et al. Among authors: xu t. Clin Rheumatol. 2014 Feb;33(2):291-2. doi: 10.1007/s10067-013-2418-9. Epub 2013 Nov 21. Clin Rheumatol. 2014. PMID: 24258070 No abstract available.

10

MicroRNA-323-3p with clinical potential in rheumatoid arthritis, Alzheimer's disease and ectopic pregnancy.

Xu T, Li L, Huang C, Li X, Peng Y, Li J. Xu T, et al. Expert Opin Ther Targets. 2014 Feb;18(2):153-8. doi: 10.1517/14728222.2014.855201. Epub 2013 Nov 27. Expert Opin Ther Targets. 2014. PMID: 24283221 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,366 results

Search Page

Filters